Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Dr. Leyfman Discusses the Increased risk of COVID-19 and Cancer Patients

This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.

Dr. Leyfman discusses three medications that he hopes will prove to help with COVID-19:

  • Molnupiravir (which is now authorized for emergency use)
  • Mesenchymal Stem Cells that may have the following properties:
    • Antiviral
    • Immunomodulatory
    • Regenerative
  • Zofin for long COVID-19
    • amniotic fluid-derived extracellular vesicle biologic

Dr. Leyfman brings a unique and young mind to important questions. Whether his picks turn out to be the correct answers or not, he brings a fresh perspective. Please enjoy our video.

Brian Koffman MDCM (retired) MS Ed (he, him, his)
Co-Founder, Executive VP, and Chief Medical Officer
CLL Society, Inc.